Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2740)
All Articles published online
|
May 28, 2005 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Israeli E, Goldin E, Shibolet O, Klein A, Hemed N, Engelhardt D, Rabbani E, Ilan Y. Oral immune regulation using colitis extracted proteins for treatment of Crohn’s disease: Results of a phase I clinical trial. World J Gastroenterol 2005; 11(20): 3105-3111 [PMID: 15918198 DOI: 10.3748/wjg.v11.i20.3105] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i20/3105.htm |
| Number | Citing Articles |
| 1 |
Yuefang Ye, Xi Jin, Min Yue, Shaohua Chen, Chaohui Yu, Youming Li. The protective effect of oral colitis-derived proteins in a murine model of inflammatory bowel disease is associated with an increase in γδ T cells in large intestinal mucosa. International Journal of Colorectal Disease 2010; 25(9): 1055 doi: 10.1007/s00384-010-0975-9
|
| 2 |
Yaron Ilan. Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clinical & Translational Immunology 2016; 5(1) doi: 10.1038/cti.2015.47
|
| 3 |
Massimo Fusconi, Gianna Pulice, Flora Ippoliti, Romina Mastronicola, Giovanni Ralli, Marco de Vincentiis. Modification of lymphocyte subsets in patients with rhinoscleroma. American Journal of Otolaryngology 2006; 27(6): 401 doi: 10.1016/j.amjoto.2006.03.013
|
| 4 |
Yaron Ilan. Oral tolerance: Can we make it work?. Human Immunology 2009; 70(10): 768 doi: 10.1016/j.humimm.2009.06.018
|
| 5 |
Eran Israeli, Ehud Zigmond, Gadi Lalazar, Athalia Klein, Nilla Hemed, Eran Goldin, Yaron Ilan. Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial. World Journal of Gastroenterology 2015; 21(18): 5685-5694 doi: 10.3748/wjg.v21.i18.5685
|
| 6 |
Paolo Giuffrida, Sara Cococcia, Mariangela Delliponti, Marco Vincenzo Lenti, Antonio Di Sabatino. Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease. Cells 2019; 8(5): 397 doi: 10.3390/cells8050397
|
| 7 |
Maya Margalit, Eran Israeli, Oren Shibolet, Ehud Zigmond, Athalia Klein, Nilla Hemed, James J. Donegan, Elazar Rabbani, Eran Goldin, Yaron Ilan. A Double-Blind Clinical Trial for Treatment of Crohn's Disease by Oral Administration of Alequeltm, A Mixture of Autologous Colon-Extracted Proteins: A Patient-Tailored Approach. The American Journal of Gastroenterology 2006; 101(3): 561 doi: 10.1111/j.1572-0241.2006.00441.x
|
| 8 |
Jae Geun Hyun, Terrence A. Barrett. Oral Tolerance Therapy in Inflammatory Bowel Disease. The American Journal of Gastroenterology 2006; 101(3): 569 doi: 10.1111/j.1572-0241.2006.00437.x
|
| 9 |
Ad A. van Bodegraven, Cisca Wijmenga. Genomic and Personalized Medicine. 2009; : 1040 doi: 10.1016/B978-0-12-369420-1.00086-X
|
| 10 |
Ariel Kenig, Tal Keidar-Haran, Henny Azmanov, Asa Kessler, Yotam Kolben, Tamar Tayri-Wilk, Nir Kalisman, Sarah Weksler-Zangen, Yaron Ilan. Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation. Inflammation 2023; 46(3): 963 doi: 10.1007/s10753-023-01783-9
|
| 11 |
G.R. Lichtenstein. A Double-Blind Clinical Trial for Treatment of Crohn's Disease by Oral Administration of Alaquel™, A Mixture of Autologous Colon-Extracted Proteins: A Patient-Tailored Approach. Yearbook of Gastroenterology 2007; 2007: 129 doi: 10.1016/S0739-5930(08)70108-9
|
| 12 |
Eran Israeli, Yaron Ilan. Review: Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s disease. Therapeutic Advances in Gastroenterology 2010; 3(1): 23 doi: 10.1177/1756283X09351733
|
| 13 |
Ross John Porter, Caroline Andrews, Daniel Paul Brice, Scott Kenneth Durum, Mairi Hall McLean. Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?. Inflammatory Bowel Diseases 2018; 24(10): 2123 doi: 10.1093/ibd/izy230
|